Evelo Biosciences Target of Unusually High Options Trading (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the recipient of unusually large options trading activity on Wednesday. Stock investors bought 1,885 put options on the stock. This represents an increase of 1,101% compared to the average volume of 157 put options.

Evelo Biosciences Price Performance

NASDAQ EVLO remained flat at $0.00 during trading on Friday. The company’s stock had a trading volume of 58 shares, compared to its average volume of 1,491. The company has a market capitalization of $8,542.35, a P/E ratio of 0.00 and a beta of 1.29. The business’s fifty day moving average is $0.01 and its 200 day moving average is $0.03. Evelo Biosciences has a 52 week low of $0.00 and a 52 week high of $0.76.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.